4AB:ETR
AbbVie Common Stock
259,70 €
arrow_downward
-1,18%(-3,10) 1D
6-ноя., 17:35:52 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
254,90 €
High
259,70 €
Low
253,00 €
Mkt. cap
514,92 млд
Avg. vol.
885,00
Volume
957,00
52-wk high
270,70 €
52-wk low
162,85 €
No. of employees
57 миң
Open
254,90 €
High
259,70 €
Low
253,00 €
Mkt. cap
514,92 млд
Avg. vol.
885,00
Volume
957,00
52-wk high
270,70 €
52-wk low
162,85 €
No. of employees
57 миң
News stories
From web sources and news partners
Trefis
·
54 мүнөт мурун
What Could Stall AbbVie Stock’s Run?
Yahoo Finance
·
3 саат мурун
Why Is AbbVie (ABBV) Spending $1.37 Billion On Pipeline And UK Research?
Yahoo Finance
·
10 саат мурун
Pfizer vs. AbbVie: Higher Yield and Cheaper Valuation Give One the Clear Edge
MarketWatch
·
12 саат мурун
AbbVie Inc. stock underperforms Friday when compared to competitors despite daily gains
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websiteabbvie.com